Form D — Volastra Therapeutics, Inc.
0001968822-25-000002 · filed 2025-09-23
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $30,099,998
- Total sold
- $30,099,998
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Volastra Therapeutics, Inc.
- CIK
- 1968822
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 1361 AMSTERDAM AVENUE
NEW YORK, NY 10027 - Phone
- 646-344-1248
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Ellie McGuire · DirectorNEW YORK, NY Find on LinkedIn ↗
-
Jill Goldstein · DirectorNEW YORK, NY Find on LinkedIn ↗
-
Luc Dochez · DirectorNEW YORK, NY Find on LinkedIn ↗
-
Arjun Balar · DirectorNEW YORK, NY Find on LinkedIn ↗
-
Samuel Bakhoum · DirectorNEW YORK, NY Find on LinkedIn ↗
-
David Southwell · Executive OfficerNEW YORK, NY Find on LinkedIn ↗
-
David Nicholson · DirectorNEW YORK, NY Find on LinkedIn ↗
-
Sandra Peterson · DirectorNEW YORK, NY Find on LinkedIn ↗
-
Robert Mittendorff · DirectorNEW YORK, NY Find on LinkedIn ↗
View original on SEC EDGAR.